Comparing Calquence vs Zanubrutinib
| Calquence (acalabrutinib) | Zanubrutinib |
|
|---|
| Calquence (acalabrutinib) | Zanubrutinib |
|
|---|---|---|
|
Prescription only
Prescribed for Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma. Calquence may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Waldenström Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma. Zanubrutinib may also be used for purposes not listed in... View more |
Related suggestions Mantle Cell Lymphoma
Popular comparisons
|
| More about Calquence (acalabrutinib) | More about Zanubrutinib | |
| Ratings & Reviews | ||
|
Calquence has an average rating of 8.8 out of 10 from a total of 34 ratings on Drugs.com. 88% of reviewers reported a positive effect, while 3% reported a negative effect. |
Zanubrutinib has an average rating of 8.8 out of 10 from a total of 63 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Calquence side effects |
View all Zanubrutinib side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
||
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
|
| Brand Names | ||
|
N/A |
Brukinsa | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
6.9 hours |
4 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 510 drugs are known to interact with Calquence:
|
A total of 529 drugs are known to interact with Zanubrutinib:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
|
|
| Disease Interactions | ||
| First Approval Date | ||
|
October 31, 2017 |
November 14, 2019 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.